Work

A phase-Ib study of TRK-950 combined with anticancer treatment regimens in patients with gastric and gastro-esophageal junction (GEJ) cancer.

Year: 2023

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2023.41.4_suppl.361

Authors: Philippe Alexandre Cassier, Marc Ryan Matrana, Diana L. Hanna, Ben George, Sunil Sharma, Ronan Joseph Kelly, Fumiyoshi Okano, Daniel D. Von Hoff, Jean-Yves Blay

Institutions: Centre Léon Bérard, Ochsner Medical Center, USC Norris Comprehensive Cancer Center, Medical College of Wisconsin, HonorHealth, Baylor University Medical Center, Toray Industries, Inc. (Japan), Translational Genomics Research Institute

Language: English

Topic: Gastric Cancer Management and Outcomes

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4318904032

Cites:

Cited by: 2

Related to: 10